AU6821196A - Transdermal administration of vorozole - Google Patents

Transdermal administration of vorozole

Info

Publication number
AU6821196A
AU6821196A AU68211/96A AU6821196A AU6821196A AU 6821196 A AU6821196 A AU 6821196A AU 68211/96 A AU68211/96 A AU 68211/96A AU 6821196 A AU6821196 A AU 6821196A AU 6821196 A AU6821196 A AU 6821196A
Authority
AU
Australia
Prior art keywords
vorozole
transdermal administration
transdermal
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU68211/96A
Inventor
Theo Cesar Garrevoet
Jean-Louis Mesens
Marcus Joannes Maria Noppe
Jozef Peeters
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of AU6821196A publication Critical patent/AU6821196A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
AU68211/96A 1995-08-14 1996-08-08 Transdermal administration of vorozole Abandoned AU6821196A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95202204 1995-08-14
EP95202204 1995-08-14
PCT/EP1996/003558 WO1997006788A1 (en) 1995-08-14 1996-08-08 Transdermal administration of vorozole

Publications (1)

Publication Number Publication Date
AU6821196A true AU6821196A (en) 1997-03-12

Family

ID=8220567

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68211/96A Abandoned AU6821196A (en) 1995-08-14 1996-08-08 Transdermal administration of vorozole

Country Status (4)

Country Link
AR (1) AR003979A1 (en)
AU (1) AU6821196A (en)
WO (1) WO1997006788A1 (en)
ZA (1) ZA966842B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1302289B1 (en) 1998-09-30 2000-09-05 Univ Catania PHARMACEUTICAL COMPOSITIONS WITH ANTINEOPLASTIC ACTIVITY
US6277401B1 (en) 1999-05-07 2001-08-21 U.S. Dermatologics, Inc. Drug delivery device
JP2003518009A (en) * 1999-07-06 2003-06-03 ザ、プロクター、エンド、ギャンブル、カンパニー Sheet member
AU3246000A (en) * 1999-07-06 2001-01-22 Procter & Gamble Company, The Cosmetic or dermapharmaceutical patch
DE10042411A1 (en) * 2000-08-30 2002-03-28 Lohmann Therapie Syst Lts Transdermal therapeutic system for the delivery of exemestane
JP2006519879A (en) 2003-03-12 2006-08-31 エピトーム・フアーマシユーテイカルズ・リミテツド Immediately absorbable lipophilic dermatological composition and use thereof
DE102007032468A1 (en) 2007-07-10 2009-01-15 Brätter, Christian, Dr. Transdermal therapeutic systems containing the active substance anastrozole
DE102010046464A1 (en) 2009-03-19 2011-04-21 Amw Gmbh Transdermal system, useful for indicating breast cancer in postmenopausal women, comprises aromatase inhibitor, drug-impermeable skin protective layer, reservoir, optional drug-permeable membrane and a carrier for reservoir or membrane
DE102010026883A1 (en) 2010-03-11 2011-12-15 Amw Gmbh Transdermal system useful e.g. for indication of breast cancer with progesterone-receptor positive status, comprises e.g. aromatase inhibitor, active substance puller protection layer, active substance reservoir

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0165781A1 (en) * 1984-06-18 1985-12-27 Eli Lilly And Company Aromatase inhibiting N-substituted imidazole derivatives
NZ224714A (en) * 1987-06-01 1990-03-27 Janssen Pharmaceutica Nv Substituted benzotriazole derivatives and pharmaceutical compositions
CA2002859C (en) * 1988-11-29 1998-12-29 Jean P. F. Van Wauwe Method of treating epithelial disorders
GB2256135B (en) * 1991-05-31 1995-01-18 Orion Yhtymae Oy Transdermal administration of 4-substituted imidazoles
EP0593807A1 (en) * 1992-10-22 1994-04-27 LTS Lohmann Therapie-Systeme GmbH & Co. KG Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
JP2700595B2 (en) * 1992-05-21 1998-01-21 呉羽化学工業株式会社 Anti-aromatase agent containing azole derivative

Also Published As

Publication number Publication date
WO1997006788A1 (en) 1997-02-27
AR003979A1 (en) 1998-09-30
ZA966842B (en) 1998-02-16

Similar Documents

Publication Publication Date Title
AU7070596A (en) Transdermal administration of olanzapine
AU5397996A (en) Iontophoretic transdermal system for the administration of at least two substances
AU7236596A (en) Transdermal administration of ropinirole and analogs thereof
AU7166496A (en) Electroincorporation enhanced transdermal delivery of molecules
EP0800364A4 (en) Transdermal administration of apomorphine
AU6094996A (en) Diphosphonate derivatives of therapeutic agents
AU5268696A (en) Novel compounds and methods for therapy
AU1041599A (en) Therapeutic uses of triazolo-pyridazine derivatives
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
EP0941039A4 (en) Transdermal administration of ment
GB9512290D0 (en) Uses of polyhexanide
AU4656596A (en) Transdermal formulation
AU1429697A (en) Systems and methods for the transdermal administration of androgenic agents
AU6517396A (en) Preparation of N-substituted 3-hydroxypyrazoles
AU2939897A (en) Administration of histamine for therapeutic purposes
AU4774296A (en) Transdermal formulation
AU6821196A (en) Transdermal administration of vorozole
AU4914396A (en) Transdermal formulation
AU5315096A (en) 19-oxygenated steroids as therapeutic agents
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU6617798A (en) Extensible transdermal therapeutic system
HK1015681A1 (en) Rate-controlled transdermal administration of risperidone
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU4877196A (en) Derivatives of 3-pyrrolidylidene-2-one-cephalosporines
AU6829696A (en) Treatment of solutions